The Mary&May Tranexamic Acid and Glutathione Eye Cream addresses both: Tranexamic Acid disrupts the signalling pathway that drives surface pigmentation, while Glutathione shifts melanin synthesis toward lighter production through cellular antioxidant activity that also addresses the oxidative conditions contributing to vascular visibility
Consistent use for 60 days (full bottle) for noticeable results in skin glow and detox
The other recent, major arrival is orforglipron (Foundayo), a small-molecule oral GLP-1 from Eli Lilly that the FDA approved for chronic weight management in April 2026
Recent evidence, however, suggests that AT plays a role in cutaneous homeostasis, fitness, and appearance
Glucagon-like peptide-1 (GLP-1) mimetics are a class of recently developed diabetes therapy that do not lead to hypoglycemic, but some reports have suggested a relationship between GLP-1 mimetics and ketogenesis